[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334307-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334307-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","methyltransferase-dnmt3b-promotes-colorectal-cancer-cell-proliferation-by-inhibiting-plcg2","Methyltransferase DNMT3B promotes colorectal cancer cell proliferation by inhibiting PLCG2","","Aberrant DNA methylation patterns in the promoter region of PLCG2 are linked to dysregulated signaling pathways and altered cellular functions, while PLCG2’s role in colorectal cancer remains unclear. The study measures DNMT3B expression in colorectal cancer using qRT-PCR, and evaluates DNMT3B and PLCG2 protein levels with Western blotting and immunohistochemistry. Proliferation is assessed by CCK-8 and colony formation assays. Methylation-specific PCR and bisulfite-sequencing PCR quantify DNA methylation changes. Results indicate DNMT3B overexpression in TCGA datasets and higher expression in tumor tissues versus adjacent non-tumor tissues. Colorectal cancer cell lines show elevated PLCG2 methylation, and PLCG2 overexpression inhibits growth of colorectal cancer xenograft tumors in vivo.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/methyltransferase-dnmt3b-promotes-colorectal-cancer-cell-proliferation-by-inhibiting-plcg2/334307/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/methyltransferase-dnmt3b-promotes-colorectal-cancer-cell-proliferation-by-inhibiting-plcg2/334307.png","ImageObject",300,407,{"name":42,"@type":43},"Theodora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How was DNMT3B expression and PLCG2 protein level evaluated in colorectal cancer?","Question",{"text":63,"@type":64},"DNMT3B expression was measured by qRT-PCR. Western blot analysis and immunohistochemistry were used to analyze DNMT3B and PLCG2 protein levels in colorectal tissues and cell lines.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What assays were used to assess colorectal cancer cell proliferation?",{"text":68,"@type":64},"Cell Counting Kit-8 (CCK-8) and colony formation assays were used to assess proliferation of colorectal cancer cells.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism does the study propose for DNMT3B’s effect on colorectal cancer progression?",{"text":72,"@type":64},"DNMT3B inhibits PLCG2 transcription by methylating the PLCG2 promoter region, and DNMT3B controls colorectal cancer cell proliferation through PLCG2.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334307,1790179737,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":4},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Original Article  \nMethyltransferase DNMT3B promotes colorectal cancer cell proliferation by inhibiting PLCG2  \nYong Ji 1,3,5,6,†, Yang Wang2,5,6,†, Jiacheng Zou1,5,6, Guanghao Liu2,5,6, Mingyu Xia4,5,6, Jun Ren2,5,6, *, and Daorong Wang 1,2,5,6, *  \n1The Yangzhou School of Clinical Medicine of Dalian Medical University, Yangzhou 225001, China, 2Clinical Medical College, Yangzhou University, Yangzhou 225001, China, 3Jingjiang People’s Hospital, Jingjiang 214500, China, 4The Yangzhou Clinical Medical College of Xuzhou Medical University, Yangzhou 225001, China, 5General Surgery Institute of Yangzhou, Yangzhou University, Yangzhou 225001, China, and  \n6Yangzhou Key Laboratory of Basic and Clinical Transformation of Digestive and Metabolic Diseases, Yangzhou 225001, China †These authors contributed equally to this work.  \n*Correspondence address. Tel: +86-18051062590; [E-mail:](E-mail: wdaorong666@sina.com)[ wdaorong666@sina.com](E-mail: wdaorong666@sina.com) (D.W. ) / E-mail: [freezingfall@163.com](freezingfall@163.com) (J. R. ) Received 1 February 2024 Accepted 23 April 2024  \nAbstract  \nAberrant DNA methylation patterns in the promoter region of PLCG2 are associated with dysregulated signaling pathways and cellular functions. Its role in colorectal cancer cells is still unknown. In this study, qRT-PCR is used to measure DNMT3B expression in colorectal cancer. Western blot analysis and immunohistochemistry are used to analyze DNMT3B and PLCG2 protein levels in colorectal tissues and cell lines. Cell Counting Kit-8 (CCK-8) and colony formation assays are used to assess the proliferation of colorectal cancer cells. Methylation-specific PCR (MSP) and bisulfite-sequencing PCR (BSP) are used to measure DNA methylation level. Our results show that DNMT3B is overexpressed in colorectal cells in the TCGA datasets according to Kaplan-Meier plots. DNMT3B is significantly overexpressed in tumor tissues compared to that in adjacent nontumor tissues. Western blot analysis results demonstrate high expression of DNMT3B in tumor tissues. Compared to normal colonic epithelial cells, colorectal cancer cell lines exhibit elevated level of PLCG2 methylation. Overexpression of PLCG2 effectively prevents the growth of colorectal cancer xenograft tumors in vivo. PLCG2 is identified as a key downstream regulatory protein of DNMT3B in colorectal cancer. DNMT3B inhibits PLCG2 transcription through methylation of the PLCG2 promoter region. DNMT3B controls colorectal cancer cell proliferation through PLCG2, which is useful for developing therapeutic approaches that target PLCG2 expression for the treatment of colorectal cancer.  \nKey words epigenetics, DNA methylation, DNMT3B, PLCG2, colorectal cancer  \nIntroduction  \nColorectal cancer (CRC) is the third most common and deadly tumor type worldwide, although great progress has been made in CRC treatment over the past few years [1] . Although there have been some advancements in early diagnosis, the current surgical and chemoradiotherapy treatments are not optimal [2] . This is attributed to the pathological stage, invasion, and metastasis of CRC cells, which compromise the effectiveness of the treatment [3] .  \nDNA methylation plays a crucial role in the initiation and progression of CRC [4‒6] . It is an epigenetic modification involving the addition of methyl groups to DNA molecules. In CRC, DNA methylation typically involves the increased or decreased methyla-  \ntion of certain genes, potentially leading to changes in the expression levels of these genes.  \nGenerally, in CRC, tumor suppressor genes often undergo increased methylation, suppressing their function and diminishing their ability to resist cancer [7] . Conversely, some oncogenes may undergo decreased methylation, resulting in their overactivation and promoting the growth and spread of cancer cells [8] . Furthermore, the patterns and extent of DNA methylation can serve as markers for the diagnosis and prognosis of CRC [9‒11] . Therefore, gainin","cbCain7vjr7Dtkd1","https://ap.wps.com/l/cbCain7vjr7Dtkd1","pdf",2535774,12,"English","# Abstract\n## Methods used to assess gene expression, protein levels, proliferation, and methylation\n## Key findings from TCGA, tissues, cell lines, and xenograft models\n## Mechanistic conclusion and therapeutic implications","[{\"question\":\"How was DNMT3B expression and PLCG2 protein level evaluated in colorectal cancer?\",\"answer\":\"DNMT3B expression was measured by qRT-PCR. Western blot analysis and immunohistochemistry were used to analyze DNMT3B and PLCG2 protein levels in colorectal tissues and cell lines.\"},{\"question\":\"What assays were used to assess colorectal cancer cell proliferation?\",\"answer\":\"Cell Counting Kit-8 (CCK-8) and colony formation assays were used to assess proliferation of colorectal cancer cells.\"},{\"question\":\"What mechanism does the study propose for DNMT3B’s effect on colorectal cancer progression?\",\"answer\":\"DNMT3B inhibits PLCG2 transcription by methylating the PLCG2 promoter region, and DNMT3B controls colorectal cancer cell proliferation through PLCG2.\"}]","Methyltransferase DNMT3B promotes colorectal cancer cell proliferation by inhibiting PLCG2 | PDF",1790006222]